These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36581723)

  • 21. Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAF
    Lee YK; Park KH; Park SH; Kim KJ; Shin DY; Nam KH; Chung WY; Lee EJ
    Head Neck; 2018 Oct; 40(10):2271-2279. PubMed ID: 29935011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aggressive Subtypes of Papillary Thyroid Carcinoma Smaller Than 1 cm.
    Lee JS; Lee JS; Yun HJ; Kim SM; Chang H; Lee YS; Chang HS; Park CS
    J Clin Endocrinol Metab; 2023 May; 108(6):1370-1375. PubMed ID: 36546348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bilateral papillary thyroid cancer in children: Risk factors and frequency of postoperative diagnosis.
    Baumgarten H; Jenks CM; Isaza A; Bhatti T; Mostoufi-Moab S; Kazahaya K; Adzick NS; Bauer AJ
    J Pediatr Surg; 2020 Jun; 55(6):1117-1122. PubMed ID: 32171533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction mode of more than 5 central lymph nodes metastases in clinically node-negative ipsilateral papillary thyroid carcinoma with tumor size 1 to 4 cm.
    Jin L; Sun HL; Zhou L; Xie L; Zhuang YY; Wang JB
    Medicine (Baltimore); 2020 Apr; 99(16):e19809. PubMed ID: 32311998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases.
    Liu W; Cheng R; Su Y; Diao C; Qian J; Zhang J; Ma Y; Fan Y
    Medicine (Baltimore); 2017 Oct; 96(43):e8365. PubMed ID: 29069024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes of radiofrequency ablation for solitary T1aN0M0 versus T1bN0M0 papillary thyroid carcinoma: a propensity-matched cohort study.
    Tong M; Wang L; Gai Z; Zhu Y; Che Y
    Int J Hyperthermia; 2023; 40(1):2257908. PubMed ID: 37848402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and prognosis value of the number of metastatic lymph nodes in patients with papillary thyroid carcinoma.
    Zhan L; Feng HF; Yu XZ; Li LR; Song JL; Tu Y; Yuan JP; Chen C; Sun SR
    BMC Surg; 2022 Jun; 22(1):235. PubMed ID: 35725426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognosis of Patients with 1-4 cm Papillary Thyroid Cancer Who Underwent Lobectomy: Focus on Gross Extrathyroidal Extension Invading Only the Strap Muscles.
    Jang A; Jin M; Kim WW; Jeon MJ; Sung TY; Song DE; Kim TY; Chung KW; Kim WB; Shong YK; Lee YM; Kim WG
    Ann Surg Oncol; 2022 Nov; 29(12):7835-7842. PubMed ID: 35907995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Factors for Contralateral Occult Carcinoma in Patients With Unilateral Papillary Thyroid Carcinoma: A Retrospective Study and Meta-Analysis.
    Zhang F; Zheng B; Yu X; Wang X; Wang S; Teng W
    Front Endocrinol (Lausanne); 2021; 12():675643. PubMed ID: 34322091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological characteristics of papillary thyroid cancer located in the isthmus with Delphian lymph node metastasis.
    Zhao J; Zhang Y; Zheng X
    Br J Oral Maxillofac Surg; 2022 Jun; 60(5):635-638. PubMed ID: 35210104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of hemithyroidectomy in papillary thyroid carcinoma with minimal extrathyroidal extension.
    Ji YB; Song CM; Kim D; Sung ES; Lee DW; Chung MS; Tae K
    Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3435-3442. PubMed ID: 31414221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ASO Author Reflections: Active Surveillance may be Possible in Patients with T1b Papillary Thyroid Carcinoma Over 55 Years of Age Without High-Risk Features on Preoperative Examinations.
    Won HR; Jeon E; Heo DB; Chang JW; Shong M; Kim JR; Ko H; Kang YE; Yi HS; Lee JH; Joung KH; Kim JM; Lee Y; Kim SW; Jeong YJ; Ji YB; Tae K; Koo BS;
    Ann Surg Oncol; 2023 Apr; 30(4):2254-2255. PubMed ID: 36629990
    [No Abstract]   [Full Text] [Related]  

  • 33. Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma.
    Hu D; Lin H; Zeng X; Wang T; Deng J; Su X
    World J Surg; 2020 May; 44(5):1498-1505. PubMed ID: 31863139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological significance of cancer-associated fibroblasts in papillary thyroid carcinoma: a predictive marker of cervical lymph node metastasis.
    Cho JG; Byeon HK; Oh KH; Baek SK; Kwon SY; Jung KY; Woo JS
    Eur Arch Otorhinolaryngol; 2018 Sep; 275(9):2355-2361. PubMed ID: 30019191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of histopathological features and prognosis of classical and follicular variant papillary thyroid carcinoma.
    Tunca F; Sormaz IC; Iscan Y; Senyurek YG; Terzioglu T
    J Endocrinol Invest; 2015 Dec; 38(12):1327-34. PubMed ID: 26280320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical Extent of Central Lymph Node Dissection for Papillary Thyroid Carcinoma Located in the Isthmus: A Propensity Scoring Matched Study.
    Shuai Y; Yue K; Duan Y; Zhou M; Fang Y; Liu J; Liu D; Jing C; Wu Y; Wang X
    Front Endocrinol (Lausanne); 2021; 12():620147. PubMed ID: 34211434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathological Evidence of Lymph Node Metastasis in Papillary Thyroid Carcinoma.
    Can N; Tastekin E; Ozyilmaz F; Sezer YA; Guldiken S; Sut N; Sarikas N; Oz Puyan F; Guler B; Ayturk S; Celik M
    Endocr Pathol; 2015 Sep; 26(3):218-28. PubMed ID: 26209182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative ultrasonographic features of papillary thyroid carcinoma predict biological behavior.
    Nam SY; Shin JH; Han BK; Ko EY; Ko ES; Hahn SY; Chung JH
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1476-82. PubMed ID: 23463652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma].
    Wang SX; She ZQ; An CM; Zhang XW; Li ZJ; Tang PZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):277-81. PubMed ID: 27095720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a.
    Ryu YJ; Cho JS; Park MH; Yoon JH
    BMC Surg; 2019 Jul; 19(1):78. PubMed ID: 31277631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.